Previous 10 | Next 10 |
SEATTLE, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it has closed its underwritten upsized public offering of 21,772,728 shares of its common stock, which include...
2024-02-08 06:02:13 ET More on Sana Biotechnology Sana Biotechnology: Finally Rewarding Investors, But Not Sufficiently Derisked Sana Biotechnology's One-And-Done Solution For Diabetes Impresses In NHP Model (Rating Upgrade) Sana Biotechnology: SC291 Moving Forward B...
SEATTLE, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it has priced its underwritten upsized public offering of 17,272,728 shares of its common stock at a price to ...
2024-02-07 17:11:22 ET Gainers: Arm Holdings ( ARM ) +28% . Confluent ( CFLT ) +14% . Blue Bird Corporation ( BLBD ) +14% . Comtech Telecommunications Corp. ( CMTL ) +5% . Red Rock Resorts, Inc. ( RRR ) +5% . Losers: ...
2024-02-07 16:03:34 ET More on Sana Biotechnology Sana Biotechnology: Finally Rewarding Investors, But Not Sufficiently Derisked Sana Biotechnology cools after record-breaking rally Sana Biotechnology hits 52-week high amid rising volumes Read the full arti...
SEATTLE, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it has commenced an underwritten public offering of $125.0 million of shares of its common stock. In addition,...
2024-01-25 11:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-01-17 14:00:00 ET Summary JD Henning discusses his approach to the market and emphasizes the importance of timing and using momentum gauges to avoid major market downturns. Investing vs trading portfolios. Henning advises caution in the current market and suggests focusin...
2024-01-16 14:10:03 ET Summary Demand for weight loss drugs and related stocks is high, with companies like Novo Nordisk and Eli Lilly experiencing significant returns. Omega Therapeutics may be a speculative investment opportunity in the weight loss drug market as it recently ent...
2024-01-11 15:25:32 ET Summary Sana Biotechnology, Inc. raised $600m in one of the largest-ever biotech IPOs. The company's share price had deteriorated from $25, to <$3, as its in vivo and ex-vivo allogeneic therapies made slow progress or were discarded. Sana now has two ...
News, Short Squeeze, Breakout and More Instantly...
Sana Biotechnology Inc. Company Name:
SANA Stock Symbol:
NASDAQ Market:
Goal to treat 40-60 patients in 2024 in four trials across seven indications in oncology, B-cell mediated autoimmune diseases, and type 1 diabetes Ongoing ARDENT trial for SC291 continues in B-cell malignancies; expect to report additional data in 2024 Enrolling patients in the ...
SEATTLE, May 06, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ:SANA), a company focused on changing the possible for patients throug...
SEATTLE, May 06, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at three investor conferences in May and June. The presentations will fe...